Study to Understand Clinical Characteristics, Treatment Pathway in Chronic Lymphocytic Leukemia

Clinical trial NCT04964908 · COMPLETED

Trial details

NCT number: NCT04964908
Sponsor: AstraZeneca
Status: COMPLETED
Study type: OBSERVATIONAL

Chronic Lymphocytic Leukemia

Start date: 2021-12-03
Primary completion: 2023-08-31
Enrollment: 1088

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.